GE HealthCare to Buy Sofie Biosciences for $945M

GE HealthCare has agreed to acquire Sofie Biosciences for $945 million in cash. The deal strengthens its radiopharmaceutical business and cancer detection capabilities.

Xurve View
Insights:
The logo of GE Healthcare is seen on their plant in the IDA (Industrial Development Agency) estate, in Carrigtwohill, County Cork, Ireland March 28, 2025. REUTERS/Clodagh Kilcoyne

GE HealthCare Technologies agreed on Monday afternoon to acquire Sofie Biosciences for $945M in cash, expanding its radiopharmaceuticals footprint. The transaction strengthens the medical device maker's manufacturing and distribution network for PET imaging drugs. The deal arrives amid rising M&A activity in the oncology sector as healthcare firms race to secure radioactive drug assets.